Extrapyramidal deficits in ALS: a combined biomechanical and neuroimaging study
- 188 Downloads
Extrapyramidal deficits are poorly characterised in amyotrophic lateral sclerosis (ALS) despite their contribution to functional disability, increased fall risk and their quality-of-life implications. Given the concomitant pyramidal and cerebellar degeneration in ALS, the clinical assessment of extrapyramidal features is particularly challenging.
The comprehensive characterisation of postural instability in ALS using standardised clinical assessments, gait analyses and computational neuroimaging tools in a prospective study design.
Parameters of gait initiation in the anticipatory postural adjustment phase (APA) and execution phase (EP) were evaluated in ALS patients with and without postural instability and healthy controls. Clinical and gait analysis parameters were interpreted in the context of brain imaging findings.
ALS patients with postural instability exhibit impaired gait initiation with an altered APA phase, poor dynamic postural control and significantly decreased braking index. Consistent with their clinical profile, “unsteady” ALS patients have reduced caudate and brain stem volumes compared to “steady” ALS patients.
Our findings highlight that the ALS functional rating scale (ALSFRS-r) does not account for extrapyramidal deficits, which are major contributors to gait impairment in a subset of ALS patients. Basal ganglia degeneration in ALS does not only contribute to cognitive and behavioural deficits, but also adds to the heterogeneity of motor disability.
KeywordsAmyotrophic lateral sclerosis Gait impairment Postural instability Magnetic resonance imaging Basal ganglia
The authors are grateful for the generosity and kindness of all participating patients and healthy controls. We also thank Xavier Devrelle, Sophien Mehdi, and Sara Fernandez-Vidal (ICM Foundation) for their assistance in data recording. We thank the Center for Clinical Investigation (Instititut du Cerveau et de la Moellle Epiniere, Paris, France) and Vanessa Brochard for their role in the organisation and management of the study.
This study was funded by a grant from the Association for Research on ALS (ARSLA) and the Institut National pour la Santé et la Recherche Médicale (INSERM). The research leading to these results has also received support from the programme ‘‘Investissements d’avenir’’ ANR-10-IAIHU-06.
Compliance with ethical standards
Conflicts of interest
The authors have no actual or potential conflict of interest to disclose, including any financial, personal, or other relationships with other individuals or organisations within 3 years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. Marie-Laure Welter received research support from the ‘Institut du Cerveau et de la Moelle. Epinière’ (ICM) Foundation and the Agence Nationale de la Recherche. Nicolas Termoz received research support from the Laboratoire CeRSM—EA 2931. Peter Bede is supported by the Health Research Board (HRB—Ireland; HRB EIA-2017-019), the Irish Institute of Clinical Neuroscience IICN—Novartis Ireland Research (IICN—2016), the Iris O’Brien Foundation, the Perrigo Clinician-Scientist Research Fellowship, and the Research Motor Neuron (RMN-Ireland) Foundation Ireland. Pierre-François Pradat received research support from the French Association for Research in ALS (ARSla), the Institute for Research in Spinal Cord and Brain (IRME), the French Association for Myopathie (AFM-Telethon), Paris Institute of Translational Neuroscience (IHU-A-ICM), the Thierry Latran foundation, the Target ALS foundation and the Institut National pour la Santé et la Recherche Médicale (INSERM). Giovanni de Marco received research support from the Laboratoire CeRSM—EA 2931 and COMUE Université Paris Lumières.
All procedures performed in this study were fully approved by the local, institutional ethics committee (CPP Ile-de-France Paris VI; INSERM promotion RBM C12-13) and were in accordance with the 1964 Helsinki Declaration and its later amendments. This study does not involve any methods or experiments with animals.
All study participants provided informed consent prior to inclusion in the study.
Amyotrophic lateral sclerosis
Anticipatory postural adjustment
Centre of mass
Centre of foot pressure
Foot-off of the swing leg
Foot-off of the stance leg
Magnetic resonance imaging
ALS patients without postural instability
ALS patients with postural instability
Minimum vertical velocity of the CoM
CoM vertical velocity of the CoM at time of foot contact
Maximum anteroposterior velocity of the CoM
- 1.Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, Traynor BJ, Van den Berg LH, Veldink JH, Vucic S, Kiernan MC (2013) Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 12:310–322CrossRefPubMedPubMedCentralGoogle Scholar
- 4.Bede P, Bokde A, Elamin M, Byrne S, McLaughlin RL, Jordan N, Hampel H, Gallagher L, Lynch C, Fagan AJ, Pender N, Hardiman O (2013) Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry 84:766–773CrossRefPubMedGoogle Scholar
- 18.Peterson DS, Horak FB (2016) Neural control of walking in people with Parkinsonism. Physiology (Bethesda Md) 31:95–107Google Scholar
- 25.Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EGP, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain J Neurol 134:2456–2477CrossRefGoogle Scholar
- 31.Snow BJ, Peppard RF, Guttman M, Okada J, Martin WR, Steele J, Eisen A, Carr G, Schoenberg B, Calne D (1990) Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in Lytico-Bodig. The amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam. Arch Neurol 47:870–874CrossRefPubMedGoogle Scholar
- 39.Brettschneider J, Arai K, Del Tredici K, Toledo JB, Robinson JL, Lee EB, Kuwabara S, Shibuya K, Irwin DJ, Fang L, Van Deerlin VM, Elman L, McCluskey L, Ludolph AC, Lee VM, Braak H, Trojanowski JQ (2014) TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol 128:423–437CrossRefPubMedPubMedCentralGoogle Scholar
- 42.Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rub U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466:1069–1075CrossRefPubMedPubMedCentralGoogle Scholar
- 58.Bede P, Omer T, Finegan E, Chipika RH, Iyer PM, Doherty MA, Vajda A, Pender N, McLaughlin RL, Hutchinson S, Hardiman O (2018) Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging Behav. https://doi.org/10.1007/s11682-018-9837-9 PubMedCrossRefGoogle Scholar